Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens

Author:

Siegel Stuart E.1,Advani Anjali2,Seibel Nita3,Muffly Lori4,Stock Wendy5,Luger Selina6,Shah Bijal7,DeAngelo Daniel J.8,Freyer David R.9,Douer Dan10,Johnson Rebecca H.11,Hayes-Lattin Brandon12,Lewis Mark13,Jaboin Jerry J.14,Coccia Peter F.15,Bleyer Archie16ORCID

Affiliation:

1. Critical Mass Young Adult Cancer Alliance; Washington District of Columbia

2. Cleveland Clinic; Cleveland Ohio and SWOG

3. Cancer Therapy Evaluation Program, National Cancer Institute; Bethesda Maryland and Children's Oncology Group

4. Department of Medicine; Blood and Marrow Transplantation, Stanford University; Palo Alto California and SWOG

5. University of Chicago; Chicago Illinois and The Alliance

6. University of Pennsylvania; Philadelphia Pennsylvania and ECOG-ACRIN

7. Moffitt Cancer Center; Tampa Florida and SWOG

8. Department of Medical Oncology, Dana Farber Cancer Institute ALL Consortium; Dana Farber Cancer Institute; Boston Massachusetts

9. University of Southern California, Norris Comprehensive Cancer Center; Los Angeles California and Children's Oncology Group

10. Department of Medicine; University of Southern California; Los Angeles California and ECOG-ACRIN

11. Mary Bridge Children's Hospital and Health Center, National Clinical Oncology Research Program and Tacoma General Hospital; Tacoma Washington and SWOG, Children's Oncology Group

12. Oregon Health and Science University; Portland Oregon and SWOG

13. Department of Hematology/Oncology; Intermountain Healthcare; Salt Lake City Utah and SWOG

14. Department of Radiation Oncology; Oregon Health and Science University; Portland Oregon and NRG Oncology Group

15. Department of Pediatrics; University of Nebraska Medical Center; Omaha Nebraska and Children's Oncology Group

16. Department of Radiation Oncology; Oregon Health and Science University; Portland Oregon and Children's Oncology Group

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3